Generate Biomedicines, Inc.
GENB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002100782
In the last 90 days, Generate Biomedicines, Inc. insiders filed 0 open-market purchases and 1 sale; 86 institutions reported holding it in 13F filings for Q2 2026, worth $1.69B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Generate Biomedicines, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 57
- +57 vs. Q4 2025
- Shares held
- 92.8M
- +92.8M vs. Q4 2025
- Total value
- $1.16B
- +$1.16B vs. Q4 2025
- New holders
- 57
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GENB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $1.69B |
| Q1 2026 | 57 | $1.16B |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Generate Biomedicines, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 1 | $12 | 0.00% | +1 | New |
| Avion Wealth | 100 | $1.00K | 0.00% | +100 | New |
| Royal Bank of Canada | 231 | $3.00K | 0.00% | +231 | New |
| Wells Fargo & Company | 1,200 | $15.0K | 0.00% | +1,200 | New |
| Vanguard Global Advisers, LLC | 1,225 | $15.3K | 0.00% | +1,225 | New |
| Citigroup Inc | 2,244 | $28.1K | 0.00% | +2,244 | New |
| FNY Investment Advisers, LLC | 3,000 | $37.0K | 0.02% | +3,000 | New |
| Albion Financial Group | 4,854 | $60.7K | 0.00% | +4,854 | New |
| Parallel Advisors, LLC | 5,550 | $69.4K | 0.00% | +5,550 | New |
| Diametric Capital, LP | 10,497 | $131.2K | 0.03% | +10,497 | New |
| Hudson Bay Capital Management LP | 16,678 | $208.5K | 0.00% | +16,678 | New |
| Vanguard Fiduciary Trust Co | 17,456 | $218.2K | 0.00% | +17,456 | New |
| Y-Intercept (Hong Kong) Ltd | 18,362 | $229.5K | 0.00% | +18,362 | New |
| Davy Global Fund Management Ltd | 19,203 | $240.0K | 0.02% | +19,203 | New |
| Tudor Investment Corp Et Al | 23,833 | $297.9K | 0.00% | +23,833 | New |
| Federated Hermes, Inc. | 30,000 | $375.0K | 0.00% | +30,000 | New |
| Bank of America Corp | 34,196 | $427.4K | 0.00% | +34,196 | New |
| Squarepoint Ops LLC | 37,203 | $465.0K | 0.00% | +37,203 | New |
| Nikko Asset Management Americas, Inc. | 40,344 | $499.5K | 0.01% | +40,344 | New |
| Sumitomo Mitsui Trust Holdings, Inc. | 40,344 | $504.3K | 0.00% | +40,344 | New |
| TD Asset Management Inc | 42,866 | $535.8K | 0.00% | +42,866 | New |
| Qube Research & Technologies Ltd | 50,221 | $627.8K | 0.00% | +50,221 | New |
| HRT Financial LP | 58,762 | $734.0K | 0.00% | +58,762 | New |
| Barclays PLC | 70,894 | $886.2K | 0.00% | +70,894 | New |
| Manufacturers Life Insurance Company, The | 74,312 | $928.9K | 0.00% | +74,312 | New |
| Balyasny Asset Management LLC | 79,489 | $993.6K | 0.00% | +79,489 | New |
| Ameriprise Financial Inc | 87,335 | $1.09M | 0.00% | +87,335 | New |
| D. E. Shaw & Co., Inc. | 95,000 | $1.19M | 0.00% | +95,000 | New |
| LMR Partners LLP | 100,000 | $1.25M | 0.01% | +100,000 | New |
| Silverarc Capital Management, LLC | 100,000 | $1.25M | 0.15% | +100,000 | New |
| Geode Capital Management, LLC | 118,243 | $1.48M | 0.00% | +118,243 | New |
| Jane Street Group, LLC | 123,371 | $1.54M | 0.00% | +123,371 | New |
| Seven Grand Managers, LLC | 125,000 | $1.56M | 0.10% | +125,000 | New |
| Vanguard Capital Management LLC | 131,319 | $1.64M | 0.00% | +131,319 | New |
| Goldman Sachs Group Inc | 170,695 | $2.13M | 0.00% | +170,695 | New |
| Sphera Funds Management Ltd. | 185,000 | $2.31M | 0.40% | +185,000 | New |
| CenterBook Partners LP | 266,813 | $3.34M | 0.18% | +266,813 | New |
| ExodusPoint Capital Management, LP | 311,986 | $3.90M | 0.04% | +311,986 | New |
| Morgan Stanley | 337,302 | $4.22M | 0.00% | +337,302 | New |
| Affinity Asset Advisors, LLC | 350,000 | $4.38M | 0.26% | +350,000 | New |
| UBS Group AG | 356,704 | $4.46M | 0.00% | +356,704 | New |
| Millennium Management LLC | 376,893 | $4.71M | 0.00% | +376,893 | New |
| ARK Investment Management LLCSuperinvestorARK Invest | 498,408 | $6.23M | 0.05% | +498,408 | New |
| Alyeska Investment Group, L.P. | 500,000 | $6.25M | 0.02% | +500,000 | New |
| Davern Capital Partners, LP | 591,800 | $7.40M | 2.03% | +591,800 | New |
| Siren, L.L.C. | 736,104 | $9.20M | 0.26% | +736,104 | New |
| NVIDIA Corp | 833,325 | $10.4M | 0.06% | +833,325 | New |
| Harvard Management Co Inc | 1,111,100 | $13.9M | 0.76% | +1,111,100 | New |
| Baker Bros. Advisors LP | 1,423,602 | $17.8M | 0.10% | +1,423,602 | New |
| HarbourVest Partners LLC | 1,722,210 | $21.5M | 21.33% | +1,722,210 | New |
| ARCH Venture Management, LLC | 1,944,426 | $24.3M | 3.59% | +1,944,426 | New |
| Price T Rowe Associates Inc | 2,109,633 | $26.4M | 0.00% | +2,109,633 | New |
| JPMorgan Chase & Co | 2,947,259 | $33.9M | 0.00% | +2,947,259 | New |
| Braidwell LP | 3,592,999 | $44.9M | 1.50% | +3,592,999 | New |
| Capital World Investors | 4,004,149 | $50.1M | 0.01% | +4,004,149 | New |
| FMR LLC | 4,217,524 | $52.7M | 0.00% | +4,217,524 | New |
| Flagship Pioneering Inc. | 62,673,117 | $783.4M | 67.44% | +62,673,117 | New |